Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05686291
Other study ID # 2021-2022-0403
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2022
Est. completion date December 31, 2023

Study information

Verified date February 2024
Source Education University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As the effectiveness of the hybrid volunteer training in Hong Kong is under-studied, this experimental study aims to develop a hybrid learning mode of volunteer training that increase volunteering-related self-efficacy and its associated outcomes among volunteer. In particular, this study compares the efficacy of hybrid volunteer training with the wait-list control group. The volunteer training will consist of a 6-module online course, followed by 5 face-to-face courses. Each module will consist of the key volunteer training component presented in in written or video format. Materials will be presented interactively to facilitate engagement.


Description:

Mental illness poses a challenge to public mental health services because of its high prevalence, symptom chronicity, and impacts on patients and society. Although there is a huge amount of need to serve people with mental illness, there is insufficient manpower. There is much empirical evidence to support the volunteer programs for people with mental illness. However, the literature on hybrid volunteer training is mainly focused on teaching and learning in education, and the effectiveness of the hybrid volunteer training in Hong Kong is under-studied. Therefore, The present study aims to compare the efficacy of hybrid volunteer training with the wait-list control group. We hypothesize that (1) participants who receive hybrid volunteer training will increase their self-efficacy of volunteering after the intervention as compared with the wait-list controls; (2) participants from hybrid volunteer training will have better mental health knowledge and less mental health-related stigmatized beliefs and behavior after the intervention as compared with the wait-list controls. The volunteer training will consist of a 6-module online course, followed by 5 face-to-face courses, incorporating the key volunteer training components, including Keyes theory, bio-psycho-social model, stress bucket model, recovery model and CHIME model. Each module will consist of the key volunteer training component presented in in written or video format. Materials will be presented interactively to facilitate engagement.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date December 31, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Hong Kong residents - Age =18 years - Willing to participate in volunteer service - Being able to read Chinese - Have a computer, tablet and/or smartphone device with Internet access - Have a regular email address - Willing to give informed consent and comply with the trial protocol Exclusion Criteria: - Unable to communicate with Cantonese.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Hybrid volunteer training programme
The volunteer training will consist of a 6-module online course, followed by 5 face-to-face courses, incorporating the key volunteer training components, including Keyes theory, bio-psycho-social model, stress bucket model, recovery model and CHIME model.

Locations

Country Name City State
Hong Kong Baptist Oi Kwan Social Service Hong Kong
Hong Kong The Education University of Hong Kong Hong Kong

Sponsors (2)

Lead Sponsor Collaborator
Education University of Hong Kong Baptist Oi Kwan Social Service

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Assessment in Self-Efficacy Towards Service on the Self-Efficacy Towards Service (SETS) Scale at Post-intervention Assessment and Follow-up Assessment The SETS scale assess the change in a 5-point Likert scale, ranging from strongly disagree (1) to strongly agree (5). Before intervention, Immediately after intervention, and 4 weeks after intervention
Primary Change from Baseline Assessment in Mental Health-related Knowledge on the Mental Health Knowledge Schedule (MAKS) at Post-intervention Assessment and Follow-up Assessment The MAKS assess the change in a 5-point Likert scale, ranging from strongly disagree (1) to strongly agree (5). Before intervention and Immediately after intervention, and 4 weeks after intervention
Primary Change from Baseline Assessment in Views of Empowerment on the Empowerment Scale at Post-intervention Assessment and Follow-up Assessment The Empowerment Scale assess the change in a 9-point scale of agreement, ranging from strongly disagree (1) to strongly agree (9). Before intervention and Immediately after intervention, and 4 weeks after intervention
Primary Change from Baseline Assessment in View of Recovery on the Recovery Scale at Post-intervention Assessment and Follow-up Assessment The Recovery Scale assess the change in a 9-point scale of agreement, ranging from strongly disagree (1) to strongly agree (9). Before intervention and Immediately after intervention, and 4 weeks after intervention
Primary Change from Baseline Assessment in Mental Health-related Behaviors on the Intended Behaviour subscale of the Reported and Intended Behaviour Scale (RIBS) at Post-intervention Assessment and Follow-up Assessment The RIBS assess the change in a 5-point Likert scale, ranging from strongly disagree to engage in the stated behavior (1) to strongly agree with engaging in the stated behavior (5). Before intervention and Immediately after intervention, and 4 weeks after intervention
Primary Change from Baseline Assessment in Public Attitudes Toward Mental Illness on the Stigma and Acceptance Scale at Post-intervention Assessment and Follow-up Assessment The Stigma and Acceptance Scale assess the change in a 6-point Likert scale, ranging from strongly disagree (1) to strongly agree (6). Before intervention and Immediately after intervention, and 4 weeks after intervention
Secondary Change from Baseline Assessment in Psychological Wellbeing on the World Health Organisation-Five Well-Being Index (WHO-5) at Post-intervention Assessment and Follow-up Assessment The WHO-5 assess the change in a 6-point Likert scale, ranging from at no time (1) to all of the time (6). Before intervention and Immediately after intervention, and 4 weeks after intervention
Secondary Change from Baseline Assessment in Anxiety Symptom on the General Anxiety Disorder-7 (GAD-7) at Post-intervention Assessment and Follow-up Assessment The GAD-7 assess the change in a 4-point Likert scale, ranging from not at all (0) to nearly every day (3). Before intervention and Immediately after intervention and 4 weeks after intervention
Secondary Change from Baseline Assessment in Depressive Symptom on the Patient Health Questionnaire-9 (PHQ-9) at Post-intervention Assessment and Follow-up Assessment The PHQ-9 assess the change in a 4-point Likert scale, ranging from not at all (0) to nearly every day (3). Before intervention and Immediately after intervention, and 4 weeks after intervention
Secondary Change from Baseline Assessment in Quality of Life on the Twelve-item short-form (SF-12) health survey at Post-intervention Assessment and Follow-up Assessment The SF-12 assesses the change in a combination of 5-point and 3-point Likert scale, ranging respectively from poor/ never (1) to excellent/ very much (5), and never (1) to very much (3). Before intervention and Immediately after intervention, and 4 weeks after intervention
See also
  Status Clinical Trial Phase
Completed NCT06326723 - Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects Phase 1
Recruiting NCT00001367 - Diagnosis and History Study of Patients With Different Neurological Conditions
Completed NCT02699710 - Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects Phase 1
Completed NCT02231892 - Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study N/A
Not yet recruiting NCT06441916 - Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions Phase 1
Completed NCT03771586 - A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects Phase 1
Not yet recruiting NCT06337422 - Bioequivalence Study of Generic Celecoxib 200 mg Capsules Phase 1
Completed NCT03302182 - Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects Phase 1
Completed NCT05049343 - Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants Phase 1
Recruiting NCT01629108 - Normal Values in Hearing and Balance Testing
Completed NCT02947854 - Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant Phase 1
Completed NCT02534870 - Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects Phase 1
Completed NCT02224053 - Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers Phase 1
Completed NCT01676584 - A Study of Single Dose RO6811135 in Healthy Volunteers Phase 1
Completed NCT01684891 - A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers Phase 1
Completed NCT01697436 - A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets Phase 1
Completed NCT01711762 - A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers Phase 1
Completed NCT01414881 - Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects Phase 1
Completed NCT01579149 - A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent Phase 1
Completed NCT01433575 - A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers Phase 1